Gilead Sciences (GILD) Long-Term Investments (2009 - 2026)

Gilead Sciences (GILD) has 17 years of Long-Term Investments data on file, last reported at $983.0 million in Q1 2026.

• Quarterly Long-Term Investments changed N/A year-over-year to $983.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $983.0 million (changed N/A YoY) and the FY2025 annual result came in at $3.0 billion, changed N/A from the prior year.
• Long-Term Investments eased to $983.0 million in Q1 2026, from $3.0 billion in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $3.0 billion in Q4 2025 to a low of $983.0 million in Q1 2026.
• A 4-year average of $1.5 billion and a median of $1.3 billion in 2023 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2022 — Long-Term Investments jumped 146.46% — and 2023, when it declined 9.83%.
• Tracing GILD's Long-Term Investments over 4 years: stood at $1.2 billion in 2022, then slipped by 6.59% to $1.2 billion in 2023, then jumped by 155.72% to $3.0 billion in 2025, then sank by 66.95% to $983.0 million in 2026.
• The last three Long-Term Investments figures came in at $983.0 million (Q1 2026), $3.0 billion (Q4 2025), and $2.0 billion (Q3 2025), per Business Quant data.